AEYE Health
AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.
About
AEYE Health provides FDA-cleared, autonomous AI diagnostic screening solutions for diabetic retinopathy. Their AEYE-DS product offers instant, on-the-spot diagnosis using portable or tabletop cameras, enabling primary care physicians to screen patients at the point of care. Teams look it up for Healthcare, Optometry, Retinal Screening Ophthalmology.
Frequently asked
What does AEYE Health do?
AEYE Health is a Healthcare company that offers Hardware, Software. Teams look it up for Optometry, Retinal Screening Ophthalmology, Diabetic Retinopathy. It is based in Tel Aviv, Israel and was founded in 2016. Public records show about 39 people and $4M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has AEYE Health raised?
AEYE Health has raised a total of $4M in funding. The most recent round on record is Seed.
Where is AEYE Health headquartered?
AEYE Health is headquartered in Tel Aviv, Israel.
When was AEYE Health founded?
AEYE Health was founded in 2016.
What industry does AEYE Health operate in?
AEYE Health operates in Healthcare, Optometry, Retinal Screening Ophthalmology, Diabetic Retinopathy, Diabetes.
How many employees does AEYE Health have?
AEYE Health has approximately 39 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.